
A SpaceX Dragon capsule has splashed down safely on Earth carrying critical biomedical experiments conducted aboard the International Space Station. Among the returning payload are pioneering 3D-bioprinted blood vessel constructs designed to accelerate research into vascular aging and cardiovascular disease, alongside frozen tumor organoids treated in microgravity. NASA scientists state that analyzing how cancer cells respond to therapies in zero gravity will unlock new breakthroughs in personalized oncology treatments on Earth.
SpaceX Dragon science cargo return, 3D bioprinted blood vessels space, cancer tumor organoids ISS